Cell Signaling Technology (United States)
Cell Signaling Technology, Inc. is a privately held company that develops and produces antibodies, ELISA kits, ChIP kits, proteomic kits, and other related reagents used to study the cell signaling pathways that impact human health. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Cell Signaling Technology (United States), United States, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
69%
Total
Publications
560
Total Open
Publications
389
Total
Citations
74K
Open Access
Percentage
69%
Total
Publications
560
Total Open
Publications
389
Total
Citations
74K
Breakdown
Publisher Open
18%
Both
33%
Other Platform Open
18%
Closed
31%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 49%
139
Hybrid 15%
41
No Guarantees 36%
101
Other Platform Open
Domain 78%
222
Institution 33%
93
Preprint 13%
36
Other Internet 7%
21
Public 6%
16
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 224 |
doaj.org OAI-PMH Repository | Institution | 48 |
bioRxiv | Preprint | 30 |
DOI | Other Internet | 23 |
Harvard University | Institution | 18 |
Figshare | Public | 16 |
Massachusetts Institute of Technology | Institution | 7 |
Research Square | Preprint | 4 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 4 |
California Digital Library | Institution | 4 |